At Julius Clinical, science is the foundation. Combined with flexibility, creativity, and innovation, our scientific approach enables fast, efficient, and high quality execution of complex clinical development programs. Our skilled and loyal networks of investigators all around the world allow us to offer superior recruitment in therapeutic area’s such as cardiology, diabetes, CNS and infectious diseases.

Our partners include leading pharmaceutical, biotech, medical device, and food companies, as well as academic investigators. We focus on clinical trials that are likely to have a major impact on medicine and on people’s lives. This type of demanding research requires more than a ‘one-size-fits-all’ approach, and our fusion of scientific and operational expertise enables to deliver results efficiently, on time and budget.

Julius Clinical has on its staff internationally recognised academic leaders who are actively involved in the design, conduct, and interpretation of clinical trials. This scientific expertise and credibility, combined with personal links with peers around the world, means that the company has a truly global reach and reputation. Through our global networks we can quickly select the most appropriate and high-performing sites to take part in a trial, and ensure that investigators are inspired and motivated.

Clinical Trials

Life Sciences

Medical Devices

Pharmaceutical

Julius Clinical

Martijn W.

Ricard Quingles

Stefan Timmerman Msc Rc

Desiree Poeteray-Schroder

Nina Omerović

Maria Papakrasa

Marcel Bootsma

Guillemette Vital Durand

Eelco Brouwer

Merel Schoonmade

Diederick E. Grobbee

Eric Houtman

Hans van Dijk

Erik van Zandbergen

Julius Clinical

Org chart

Similar companies